Liposomal Bupivacaine (Exparel)

bupivacaine liposome injectable suspension · Pacira BioSciences, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Liposomal Bupivacaine (Exparel), covering 2025-07-23 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery [NA]

See pricing